Identifying patient subgroups to improve outcome, resistance and toxicity in CAR T
CAR T-cells have the potential to revolutionize the field of hematological oncology, however despite impressive efficacy data from CAR T products, some patients develop resistance, have poor outcomes,...
Author: VJHemOnc
Added: 09/19/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts